Borghi, C; Bentivenga, C; Cicero, AF; Trevisani, M; Rossi, E; Viviani, F; Maranini, B; Mulé, R; Vukatana, G; Buffa, A; Corvaglia, S; Malavolta, N, PREDICTORS OF CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS: CORRELATION BETWEEN THE PRESENCE OF CARDIOVASCULAR DISEASE AND CHARACTERISTICS OF THE JOINT DISEASE, «JOURNAL OF HYPERTENSION», 2019, 37, pp. 225 - 226 [abstract]
Cicero AF, Fogacci F, Banach M, Red yeast rice for hypercholesterolemia, «METHODIST DEBAKEY CARDIOVASCULAR JOURNAL», 2019, 15, pp. 192 - 199 [articolo]
Arrigo F.G. Cicero, Massimiliano Ruscica, Maciej Banach, Resveratrol and cognitive decline: a clinician perspective., «ARCHIVES OF MEDICAL SCIENCE», 2019, 15, pp. 936 - 943 [articolo]Open Access
Federica Fogacci, Silvia Fogacci, Arrigo Cicero, Resveratrol for High Blood Pressure: A Total Failure or the Need to Identify the Right Patient?, «HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION», 2019, 26, pp. 421 - 423 [articolo]
Cosentino E.R.; Degli Esposti D.; Miceli R.; Bentivenga C.; Landolfo M.; Cicero A.; Berardi E.; Spinardi L.; Magri G.; Dugato V.; Borghi C., Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction, «CURRENT MEDICAL RESEARCH AND OPINION», 2019, 35, pp. 9 - 12 [articolo]
Strilchuk L, Fogacci F, Cicero AF, Safety and tolerability of available urate-lowering drugs: a critical review, «EXPERT OPINION ON DRUG SAFETY», 2019, 18, pp. 261 - 271 [articolo]
Strilchuk L, Fogacci F, Cicero AF, Safety and tolerability of injectable lipid-lowering drugs: an update of clinical data., «EXPERT OPINION ON DRUG SAFETY», 2019, 18, pp. 611 - 621 [articolo]
Fogacci F, Banach M, Mikhailidis DP, Bruckert E, Toth PP, Watts GF, Reiner Ž, Mancini J, Rizzo M, Mitchenko O, Pella D, Fras Z, Sahebkar A, Vrablik M, Cicero AFG; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group; International Lipid Expert Panel (ILEP)., Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials, «PHARMACOLOGICAL RESEARCH», 2019, 143, pp. 1 - 16 [articolo]
Fogacci, F; Banach, M; Mikhailidis, DP; Bruckert, E; Toth, PP; Watts, GF; Reiner, Z; Mancini, GBJ; Rizzo, M; Mitchenko, O; Pella, DP; Fras, Z; Sahebkar, AFG; Vrablik, M; Cicero, AFG, Safety of red yeast rice supplementation: a systematic review and meta-analysis of randomized controlled trials, «EUROPEAN HEART JOURNAL», 2019, 40, pp. 756 - 756 [abstract]
Cicero, AFG; Fogacci, F; D'Addato, S; Grandi, E; Giovannini, M; Rizzoli, E; Borghi, C, SERUM URIC ACID LEVELS ARE ASSOCIATED WITH ASYMPTOMATIC PERIPHERAL ARTERY DISEASE: DATA FROM THE BRISIGHELLA HEART STUDY, «JOURNAL OF HYPERTENSION», 2019, 37, pp. 165 - 165 [abstract]
Arrigo Francesco Giuseppe Cicero , Federica Fogacci , Marilisa Bove , Marina Giovannini , Maddalena Veronesi , Claudio Borghi, Short-Term Effects of Dry Extracts of Artichokeand Berberis in Hypercholesterolemic Patients Without Cardiovascular Disease, «THE AMERICAN JOURNAL OF CARDIOLOGY», 2019, 123, pp. 588 - 591 [articolo]
Fratter A, Biagi D, Cicero AFG, Sublingual Delivery of Astaxanthin through a Novel Ascorbyl Palmitate-Based Nanoemulsion: Preliminary Data, «MARINE DRUGS», 2019, 17, Article number: 508, pp. 1 - 14 [articolo]Open Access
Nasi M.; Patrizi G.; Pizzi C.; Landolfo M.; Boriani G.; Dei Cas A.; Cicero A.F.G.; Fogacci F.; Rapezzi C.; Sisca G.; Capucci A.; Vitolo M.; Galie N.; Borghi C.; Berrettini U.; Piepoli M.; Mattioli A.V., The role of physical activity in individuals with cardiovascular risk factors: An opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport, «JOURNAL OF CARDIOVASCULAR MEDICINE», 2019, 20, pp. 631-639 - 639 [articolo]
Cicero AFG, Fogacci F, Bove M, Giovannini M, Borghi C., Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects., «PHYTOTHERAPY RESEARCH», 2019, 33, pp. 2094 - 2101 [articolo]
Cosentino, ER; Cicero, AFG; Degli Esposti, D; Bentivenga, C; Magri, G; Veronesi, M; Borghi, C, ALLOPURINOL AND FEBUXOSTAT EFFECT ON TOTAL MORTALITY IN HYPERURICEMIC PATIENTS AFFECTED BY MILD-TO-MODERATE HEART FAILURE, «JOURNAL OF HYPERTENSION», 2018, 36, pp. 239 - 239 [abstract]
